Caspase 9 (CASP9) (NM_032996) Human Mass Spec Standard
CAT#: PH313375
CASP9 MS Standard C13 and N15-labeled recombinant protein (NP_127463)
Specifications
Product Data | |
Tag | C-Myc/DDK |
Species | Human |
Expression Host | HEK293 |
Expression cDNA Clone or AA Sequence | RC213375 |
Predicted MW | 30 kDa |
Protein Sequence |
>RC213375 representing NM_032996
Red=Cloning site Green=Tags(s) MDEADRRLLRRCRLRLVEELQVDQLWDVLLSRELFRPHMIEDIQRAGSGSRRDQARQLIIDLETRGSQAL PLFISCLEDTGQDMLASFLRTNRQAAKLSKPTLENLTPVVLRPEIRKPEVLRPETPRPVDIGSGGFGDVE QKDHGFEVASTSPEDESPGSNPEPDATPFQEGLRTFDQLDAISSLPTPSDIFVSYSTFPGFVSWRDPKSG SWYVETLDDIFEQWAHSEDLQSLLLRVANAVSVKGIYKQMPGCFNFLRKKLFFKTS TRTRPLEQKLISEEDLAANDILDYKDDDDKV |
Purity | > 80% as determined by SDS-PAGE and Coomassie blue staining |
Concentration | >0.05 µg/µL as determined by microplate BCA method |
Labeling Method | Labeled with [U- 13C6, 15N4]-L-Arginine and [U- 13C6, 15N2]-L-Lysine |
Buffer | 25 mM Tris-HCl, 100 mM glycine, pH 7.3 |
Storage | Store at -80°C. Avoid repeated freeze-thaw cycles. |
Stability | Stable for 3 months from receipt of products under proper storage and handling conditions. |
Reference Data | |
RefSeq | NP_127463 |
RefSeq Size | 1584 |
RefSeq ORF | 798 |
Synonyms | APAF-3; APAF3; ICE-LAP6; MCH6; PPP1R56 |
Locus ID | 842 |
UniProt ID | P55211 |
Cytogenetics | 1p36.21 |
Summary | This gene encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce two subunits, large and small, that dimerize to form the active enzyme. This protein can undergo autoproteolytic processing and activation by the apoptosome, a protein complex of cytochrome c and the apoptotic peptidase activating factor 1; this step is thought to be one of the earliest in the caspase activation cascade. This protein is thought to play a central role in apoptosis and to be a tumor suppressor. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2013] |
Protein Families | Druggable Genome, Protease, Stem cell - Pluripotency |
Protein Pathways | Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), Apoptosis, Colorectal cancer, Endometrial cancer, Huntington's disease, Non-small cell lung cancer, p53 signaling pathway, Pancreatic cancer, Parkinson's disease, Pathways in cancer, Prostate cancer, Small cell lung cancer, VEGF signaling pathway, Viral myocarditis |
Documents
FAQs |
SDS |
Resources
Recombinant Protein Resources |
Other Versions
SKU | Description | Size | Price |
---|---|---|---|
LC400491 | CASP9 HEK293T cell transient overexpression lysate (as WB positive control) |
USD 134.00 |
|
LC409796 | CASP9 HEK293T cell transient overexpression lysate (as WB positive control) |
USD 134.00 |
|
LY400491 | Transient overexpression lysate of caspase 9, apoptosis-related cysteine peptidase (CASP9), transcript variant alpha |
USD 436.00 |
|
LY409796 | Transient overexpression lysate of caspase 9, apoptosis-related cysteine peptidase (CASP9), transcript variant beta |
USD 436.00 |
|
TP313375 | Recombinant protein of human caspase 9, apoptosis-related cysteine peptidase (CASP9), transcript variant beta, 20 µg |
USD 867.00 |
|
TP761193 | Purified recombinant protein of Human caspase 9, apoptosis-related cysteine peptidase (CASP9), transcript variant alpha, full length, with N-terminal HIS tag, expressed in E. coli, 50ug |
USD 261.00 |
{0} Product Review(s)
Be the first one to submit a review